{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T18:17:30Z","timestamp":1778869050326,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,12]],"date-time":"2020-11-12T00:00:00Z","timestamp":1605139200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009438","name":"National Center of Neurology and Psychiatry","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ae0201005h0002"],"award-info":[{"award-number":["19ae0201005h0002"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["19ae0201005h9902"],"award-info":[{"award-number":["19ae0201005h9902"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["28-6"],"award-info":[{"award-number":["28-6"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy - Methods & Clinical Development"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.omtm.2020.11.003","type":"journal-article","created":{"date-parts":[[2020,11,16]],"date-time":"2020-11-16T21:12:16Z","timestamp":1605561136000},"page":"133-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment"],"prefix":"10.1016","volume":"20","author":[{"given":"Hiromi","family":"Hayashita-Kinoh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Posadas-Herrera","family":"Guillermo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuko","family":"Nitahara-Kasahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mutsuki","family":"Kuraoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Chiyo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin\u2019ichi","family":"Takeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.omtm.2020.11.003_bib1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1706198","article-title":"Single-Dose Gene-Replacement Therapy for Spinal Muscular Atrophy","volume":"377","author":"Mendell","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.11.003_bib2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/hum.2018.015","article-title":"Severe Toxicity in Nonhuman Primates and Piglets Following High-Dose Intravenous Administration of an Adeno-Associated Virus Vector Expressing Human SMN","volume":"29","author":"Hinderer","year":"2018","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib3","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1006\/mthe.2001.0491","article-title":"Lack of germline transmission of vector sequences following systemic administration of recombinant AAV-2 vector in males","volume":"4","author":"Arruda","year":"2001","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib4","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1038\/mt.2009.56","article-title":"Host and vector-dependent effects on the risk of germline transmission of AAV vectors","volume":"17","author":"Favaro","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib5","doi-asserted-by":"crossref","first-page":"3919","DOI":"10.1128\/JVI.02466-08","article-title":"Reducing the risk of adeno-associated virus (AAV) vector mobilization with AAV type 5 vectors","volume":"83","author":"Hewitt","year":"2009","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.omtm.2020.11.003_bib6","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.ymthe.2004.07.025","article-title":"AAV vector-mediated microdystrophin expression in a relatively small percentage of mdx myofibers improved the mdx phenotype","volume":"10","author":"Yoshimura","year":"2004","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib7","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1038\/sj.gt.3301829","article-title":"Adeno-associated virus vector-mediated gene transfer into dystrophin-deficient skeletal muscles evokes enhanced immune response against the transgene product","volume":"9","author":"Yuasa","year":"2002","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib8","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/mt.2011.154","article-title":"AAV-microdystrophin therapy improves cardiac performance in aged female mdx mice","volume":"19","author":"Bostick","year":"2011","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib9","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1038\/gt.2011.36","article-title":"Improvement of cardiac fibrosis in dystrophic mice by rAAV9-mediated microdystrophin transduction","volume":"18","author":"Shin","year":"2011","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/mt.2008.225","article-title":"Transduction efficiency and immune response associated with the administration of AAV8 vector into dog skeletal muscle","volume":"17","author":"Ohshima","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib11","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1038\/sj.gt.3302984","article-title":"Injection of a recombinant AAV serotype 2 into canine skeletal muscles evokes strong immune responses against transgene products","volume":"14","author":"Yuasa","year":"2007","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib12","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1172\/JCI37607","article-title":"The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice","volume":"119","author":"Zhu","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.omtm.2020.11.003_bib13","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1056\/NEJMoa1000228","article-title":"Dystrophin immunity in Duchenne\u2019s muscular dystrophy","volume":"363","author":"Mendell","year":"2010","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.omtm.2020.11.003_bib14","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/mt.2015.5","article-title":"Intra-amniotic rAAV-mediated microdystrophin gene transfer improves canine X-linked muscular dystrophy and may induce immune tolerance","volume":"23","author":"Hayashita-Kinoh","year":"2015","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib15","doi-asserted-by":"crossref","first-page":"a015560","DOI":"10.1101\/cshperspect.a015560","article-title":"Mesenchymal stromal cells in transplantation rejection and tolerance","volume":"3","author":"English","year":"2013","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"10.1016\/j.omtm.2020.11.003_bib16","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1600-6143.2012.04115.x","article-title":"Localization of mesenchymal stromal cells dictates their immune or proinflammatory effects in kidney transplantation","volume":"12","author":"Casiraghi","year":"2012","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.omtm.2020.11.003_bib17","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1097\/TP.0000000000002611","article-title":"Effect of Timing and Complement Receptor Antagonism on Intragraft Recruitment and Protolerogenic Effects of Mesenchymal Stromal Cells in Murine Kidney Transplantation","volume":"103","author":"Casiraghi","year":"2019","journal-title":"Transplantation"},{"key":"10.1016\/j.omtm.2020.11.003_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.3727\/096368917X695010","article-title":"The Timing of Immunomodulation Induced by Mesenchymal Stromal Cells Determines the Outcome of the Graft in Experimental Renal Allotransplantation","volume":"26","author":"Merino","year":"2017","journal-title":"Cell Transplant."},{"key":"10.1016\/j.omtm.2020.11.003_bib20","doi-asserted-by":"crossref","first-page":"16105","DOI":"10.1038\/ncomms16105","article-title":"Long-term microdystrophin gene therapy is effective in a canine model of Duchenne muscular dystrophy","volume":"8","author":"Le Guiner","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.omtm.2020.11.003_bib21","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mt.2015.189","article-title":"Evaluation of AAV-mediated Gene Therapy for Central Nervous System Disease in Canine Mucopolysaccharidosis VII","volume":"24","author":"Gurda","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib22","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1089\/hgtb.2014.128","article-title":"AAV-8 is more efficient than AAV-9 in transducing neonatal dog heart","volume":"26","author":"Pan","year":"2015","journal-title":"Hum. Gene Ther. Methods"},{"key":"10.1016\/j.omtm.2020.11.003_bib23","doi-asserted-by":"crossref","first-page":"5880","DOI":"10.1093\/hmg\/ddv310","article-title":"Safe and bodywide muscle transduction in young adult Duchenne muscular dystrophy dogs with adeno-associated virus","volume":"24","author":"Yue","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.omtm.2020.11.003_bib24","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1038\/mt.2010.94","article-title":"Widespread muscle expression of an AAV9 human mini-dystrophin vector after intravenous injection in neonatal dystrophin-deficient dogs","volume":"18","author":"Kornegay","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib25","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/gt.2017.72","article-title":"Systemic gene delivery transduces the enteric nervous system of guinea pigs and cynomolgus macaques","volume":"24","author":"Gombash","year":"2017","journal-title":"Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib26","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/hum.2020.182","article-title":"Moving Forward After Two Deaths in a Gene Therapy Trial of Myotubular Myopathy","volume":"31","author":"Wilson","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib27","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.omtm.2020.05.001","article-title":"Timing of Intensive Immunosuppression Impacts Risk of Transgene Antibodies after AAV Gene Therapy in Nonhuman Primates","volume":"17","author":"Samelson-Jones","year":"2020","journal-title":"Mol. Ther. Methods Clin. Dev."},{"key":"10.1016\/j.omtm.2020.11.003_bib28","doi-asserted-by":"crossref","first-page":"E9182","DOI":"10.1073\/pnas.1808648115","article-title":"Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy","volume":"115","author":"Ho","year":"2018","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.omtm.2020.11.003_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00441-018-2871-5","article-title":"Mesenchymal stromal cell-derived extracellular vesicles: regenerative and immunomodulatory effects and potential applications in sepsis","volume":"374","author":"Zheng","year":"2018","journal-title":"Cell Tissue Res."},{"key":"10.1016\/j.omtm.2020.11.003_bib30","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1016\/j.ymthe.2020.04.020","article-title":"Comprehensive Molecular Profiles of Functionally Effective MSC-Derived Extracellular Vesicles in Immunomodulation","volume":"28","author":"Kim","year":"2020","journal-title":"Mol. Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib31","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/hum.2009.006","article-title":"Scalable purification of adeno-associated virus serotype 1 (AAV1) and AAV8 vectors, using dual ion-exchange adsorptive membranes","volume":"20","author":"Okada","year":"2009","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.omtm.2020.11.003_bib32","first-page":"145","article-title":"Major clinical and histopathological characteristics of canine X-linked muscular dystrophy in Japan, CXMDJ","volume":"24","author":"Shimatsu","year":"2005","journal-title":"Acta Myol."},{"key":"10.1016\/j.omtm.2020.11.003_bib33","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/1471-2261-6-47","article-title":"Cardiac involvement in Beagle-based canine X-linked muscular dystrophy in Japan (CXMDJ): electrocardiographic, echocardiographic, and morphologic studies","volume":"6","author":"Yugeta","year":"2006","journal-title":"BMC Cardiovasc. Disord."}],"container-title":["Molecular Therapy - Methods & Clinical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302308?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2329050120302308?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T17:52:48Z","timestamp":1778867568000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2329050120302308"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":32,"alternative-id":["S2329050120302308"],"URL":"https:\/\/doi.org\/10.1016\/j.omtm.2020.11.003","relation":{},"ISSN":["2329-0501"],"issn-type":[{"value":"2329-0501","type":"print"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improved transduction of canine X-linked muscular dystrophy with rAAV9-microdystrophin via multipotent MSC pretreatment","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy - Methods & Clinical Development","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.omtm.2020.11.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s).","name":"copyright","label":"Copyright"}]}}